keyboard_arrow_up

Global Epilepsy Medicine Market Trends and Analysis 2016-2020

Report : Global Epilepsy Medicine Market 2016-2020 is a new market research publication announced by Reportstack.

Report Outline: Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology. 

Etiology: 
Etiology varies according to the age of a person. Some individuals genetically inherit the disease while the cause of the disease in others is unknown. Head injuries, tumors, autism spectrum disorder, or stroke can also cause the disorder.

For detailed report with TOC, please click here ​Global Epilepsy Medicine Market 2016-2020.

Market Growth: The global epilepsy Medicine market is expected to grow at a CAGR of 4.45% during the period 2016-2020.

Key vendors 
• Eisai
• GSK
• Pfizer
• UCB

Other prominent vendors 
• AbbVie
• Acorda Therapeutics
• Alexza Pharmaceuticals
• Aprecia Pharmaceuticals
• Aurobindo Pharma
• Biscayne Pharmaceuticals
• CURx Pharmaceuticals
• Dainippon Sumitomo Pharma
• D-Pharm
• F. Hoffmann-La Roche
• Grupo Ferrer Internacional
• GW Pharmaceuticals
• Insero Health
• INSYS Therapeutics
• Janssen Pharmaceuticals
• Ligand Pharmaceuticals
• H. Lundbeck
• MarcoPolo Pharmaceuticals
• Marinus Pharmaceuticals
• Meda
• Neurelis
• Nobelpharma
• Novartis
• Orphelia Pharma
• SAGE Therapeutics
• SciFlour
• Sedor Pharmaceuticals
• Shire
• SK Biopharmaceuticals
• Sun Pharmaceutical
• Sunovion Pharmaceuticals (US)
• Supernus Pharmaceuticals
• Takeda
• Turing Pharmaceuticals
• Upsher-Smith
• Valeant Pharmaceutical
• Zogenix

Regions Covered: 

• Americas
• APAC
• EMEA

Companies Mentioned

Eisai, GSK, Pfizer, UCB, Acorda Therapeutics, Alexza Pharmaceuticals, Aprecia Pharmaceuticals, Aurobindo Pharma, Biscayne Pharmaceuticals, CURx Pharmaceuticals, Dainippon Sumitomo Pharma, D-Pharm, F. Hoffmann-La Roche, Grupo Ferrer Internacional, GW Pharmaceuticals, Insero Health, INSYS Therapeutics, Janssen Pharmaceuticals, Ligand Pharmaceuticals, H. Lundbeck, MarcoPolo Pharmaceuticals, Marinus Pharmaceuticals, Meda, Neurelis, Nobelpharma, Novartis, Orphelia Pharma, SAGE Therapeutics, SciFlour, Sedpr Pharmaceuticals, Shire, SK Biopharmaceuticals, Sun Pharmaceutical, Sunovion Pharmaceuticals (US), Supernus Pharmaceuticals, Takeda, Turing Pharmaceuticals, Upsher-Smith, Valeant Pharmaceuticals, Zogenix.

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###